Ionizable nanoemulsions for RNA delivery into the central nervous system - importance of diffusivity

被引:3
|
作者
Borrajo, Mireya L. [1 ,2 ,3 ]
Quijano, Aloia [1 ,3 ]
Lapuhs, Philipp [1 ,2 ,3 ]
Rodriguez-Perez, Ana I. [1 ,3 ,4 ]
Anthiya, Shubaash [1 ,2 ,3 ]
Labandeira-Garcia, Jose L. [1 ,3 ,4 ]
Valenzuela, Rita [1 ,3 ,4 ]
Alonso, Maria Jose [1 ,2 ,3 ]
机构
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CiMUS, Ave Barcelona S-N,Campus Vida, Santiago De Compostela 15782, Spain
[2] Univ Santiago de Compostela, Sch Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15782, Spain
[3] Univ Santiago de Compostela, IDIS Res Inst, Santiago De Compostela 15782, Spain
[4] Networking Res Ctr Neurodegenerat Dis CIBERNED, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
Brain delivery; Diffusivity; mRNA; Nanoemulsion; RNA therapeutics; siRNA; RATIONAL DESIGN; DRUG-DELIVERY; NANOPARTICLES; NANOCAPSULES; ENDOCYTOSIS; MECHANISMS; ACID;
D O I
10.1016/j.jconrel.2024.06.051
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Lipid nanoparticles (LNPs) currently dominate the RNA delivery landscape; however their limited diffusivity hampers targeted tissue dissemination, and, hence, their capacity for intracellular drug delivery. This is especially relevant for tissues such as the central nervous system (CNS), where overcoming proactive brain barriers is crucial for the efficacy of genetic therapeutics. This research aimed to create ionizable nanoemulsions (iNEs), a new generation of RNA delivery systems with enhanced diffusivity. The developed iNEs (consisting of the combination of C12-200, DOPE, Vitamin E, and DMG-PEG) with a size below 100 nm, neutral surface charge, and high RNA loading capacity, showed excellent cell viability and transfection efficiency in various cellular models, including neurons, astrocytes, and microglia. Subsequently, iNEs containing mRNA GFP were tested for CNS transfection, highlighting their exceptional diffusivity and selective transfection of neurons following intraparenchymal administration.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 50 条
  • [1] Non-Viral Delivery of RNA Gene Therapy to the Central Nervous System
    Hauck, Ellen S.
    Hecker, James G.
    PHARMACEUTICS, 2022, 14 (01)
  • [2] Therapeutic Delivery to Central Nervous System
    Kunigelis, Katherine E.
    Vogelbaum, Michael A.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2021, 32 (02) : 291 - 303
  • [3] Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
    Xu, Yue
    Golubovic, Alex
    Xu, Shufen
    Pan, Anni
    Li, Bowen
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (28) : 6527 - 6539
  • [4] Nanomaterials for delivery of nucleic acid to the central nervous system (CNS)
    Wang, Danyang
    Wu, Lin-Ping
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 70 : 1039 - 1046
  • [5] Emerging Biological Importance of Central Nervous System Lanthionines
    Hensley, Kenneth
    Venkova, Kalina
    Christov, Alexandar
    MOLECULES, 2010, 15 (08) : 5581 - 5594
  • [6] Short interfering RNA and the central nervous system: development of nonviral delivery systems
    Nishina, Kazutaka
    Mizusawa, Hidehiro
    Yokota, Takanori
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (03) : 289 - 292
  • [7] Novel Central Nervous System Drug Delivery Systems
    Stockwell, Jocelyn
    Abdi, Nabiha
    Lu, Xiaofan
    Maheshwari, Oshin
    Taghibiglou, Changiz
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (05) : 507 - 520
  • [8] Nanobiotechnology - Based drug delivery to the central nervous system
    Jain, K. K.
    NEURODEGENERATIVE DISEASES, 2007, 4 (04) : 287 - 291
  • [9] Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
    Pandey, Manisha
    Jain, Neha
    Kanoujia, Jovita
    Hussain, Zahid
    Gorain, Bapi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
    Mendonca, Monique C. P.
    Kont, Ayse
    Aburto, Maria Rodriguez
    Cryan, John F.
    O'Driscoll, Caitriona M.
    MOLECULAR PHARMACEUTICS, 2021, 18 (04) : 1491 - 1506